Primary Causes & Pathophysiology
Metabolic acidosis occurs when net acid accumulation exceeds buffering and excretory capacity, lowering serum bicarbonate. In HAGMA, the added acid load consists of unmeasured anions (e.g., lactate, beta-hydroxybutyrate, sulphate, formate, glycolate) that replace consumed bicarbonate while chloride remains unchanged, widening the anion gap. The anion gap reflects the difference between measured cations (Na⁺) and measured anions (Cl⁻ + HCO₃⁻); normally, unmeasured anions (primarily albumin) account for 8–12 mmol/L. When pathological acids dissociate, hydrogen ions are buffered by bicarbonate, and the conjugate base accumulates as an unmeasured anion. Albumin correction is essential because each 10 g/L decrease in albumin reduces the expected anion gap by approximately 2.5 mmol/L, potentially obscuring significant pathology. Renal compensation via ammoniagenesis and titratable acid excretion is often impaired in acute settings or chronic kidney disease, exacerbating acid retention.
Tissue hypoperfusion or hypoxia drives anaerobic glycolysis, generating L-lactate faster than hepatic and renal clearance can metabolise it.
Insulin deficiency and counter-regulatory hormone excess accelerate lipolysis and hepatic ketogenesis, producing beta-hydroxybutyrate and acetoacetate.
Declining glomerular filtration impairs excretion of sulphate, phosphate, and organic anions while reducing ammoniagenesis, causing progressive anion retention.
Alcohol dehydrogenase metabolises methanol to formaldehyde and then formic acid, which inhibits mitochondrial cytochrome oxidase and accumulates as formate.
Metabolism via alcohol dehydrogenase yields glycolic acid and oxalic acid; glycolate is the primary contributor to the anion gap.
Carbohydrate depletion and elevated glucagon/insulin ratio stimulate ketogenesis, predominantly producing beta-hydroxybutyrate.